MDG — Medicalgorithmics SA Share Price
Last trade - 00:00- PLN252.80m
- PLN250.40m
- PLN43.10m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 181.43 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | -39.13% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.12 | ||
| Price to Tang. Book | 74.68 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 8.24 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -12.04% | ||
| Return on Equity | -13.85% | ||
| Operating Margin | -38.66% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | PLNm | 173.87 | 111.73 | 48.35 | 62.72 | 43.1 | 44.3 | 46.6 | -26.39% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -70.89 | n/a | n/a | +160.13 | n/a | n/a | -39.13 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Medicalgorithmics SA is a Poland-based company engaged in the advanced medical equipment and technology industry. The Company develops and manufactures system for the diagnosis of heart arrhythmia. Its product, named PocketECG, is used for remote monitoring of cardiac disorders, arrhythmia diagnosis and monitoring of heart, as well as is used for clinical drugs trials for cardiac safety. In addition, Medicalgorithmics SA provides services in the field of information technology and biotechnology, scientific research and development of natural sciences. Moreover, the Company works on the several projects, such as a device for tele-rehabilitation cardiology, software for optimizing repetitive task in hospitals, as well as devices and systems for remote description of the electrocardiography (ECG). It operates through MEDICALGORITHMICS US HOLDING CORPORATION and Medi-Lynx Cardiac Monitoring LLC and Medi-Lynx Cardiac Monitoring LLC.
Directors
- Marek Dziubinski CSU (45)
- Michal Wnorowski VSU
- Maciej Gamrota CFO
- Jaroslaw Jerzakowski MGB
- Artur Malek IND
- Mariusz Matuszewski IND
- Krzysztof Urbanowicz IND (56)
- Stanisla Borkowski SUB
- Werner Engelhardt SUB
- Andrzej Gladysz SUB
- Grzegorz Janas SUB
- Martin Jasinski SUB
- Anna Sobocka SUB
- Brandon Von Tobel SUB
- Last Annual
- December 31st, 2023
- Last Interim
- September 30th, 2024
- Incorporated
- December 10th, 2010
- Public Since
- November 9th, 2011
- No. of Employees
- 120
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Warsaw Stock Exchange
- Shares in Issue
- 9,952,769
- Address
- Central Tower Building, 18. pietro, WARSZAWA, 02-001
- Web
- https://www.medicalgorithmics.com/
- Phone
- +48 228251249
- Contact
- Robert Mrozowski
- Auditors
- UHY ECA Audyt Sp. Zoo SP. k.
Upcoming Events for MDG
Similar to MDG
Advanced Medical Equipment SA
Warsaw Stock Exchange
Airway Medix SA
Warsaw Stock Exchange
BioMaxima SA
Warsaw Stock Exchange
CM International SA
Warsaw Stock Exchange
Inventionmed SA
Warsaw Stock Exchange
FAQ
As of Today at 21:58 UTC, shares in Medicalgorithmics SA are trading at PLN25.40. This share price information is delayed by 15 minutes.
Shares in Medicalgorithmics SA last closed at PLN25.40 and the price had moved by +0.38% over the past 365 days. In terms of relative price strength the Medicalgorithmics SA share price has underperformed the FTSE Global All Cap Index by -2.13% over the past year.
The overall consensus recommendation for Medicalgorithmics SA is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreMedicalgorithmics SA does not currently pay a dividend.
Medicalgorithmics SA does not currently pay a dividend.
Medicalgorithmics SA does not currently pay a dividend.
To buy shares in Medicalgorithmics SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of PLN25.40, shares in Medicalgorithmics SA had a market capitalisation of PLN252.80m.
Here are the trading details for Medicalgorithmics SA:
- Country of listing: Poland
- Exchange: WSE
- Ticker Symbol: MDG
Based on an overall assessment of its quality, value and momentum Medicalgorithmics SA is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Medicalgorithmics SA is PLN45.20. That is 77.95% above the last closing price of PLN25.40.
Analysts covering Medicalgorithmics SA currently have a consensus Earnings Per Share (EPS) forecast of PLN0.23 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medicalgorithmics SA. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +9.66%.
As of the last closing price of PLN25.40, shares in Medicalgorithmics SA were trading +7.64% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Medicalgorithmics SA PE ratio based on its reported earnings over the past 12 months is 181.43. The shares last closed at PLN25.40.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Medicalgorithmics SA's management team is headed by:
- Marek Dziubinski - CSU
- Michal Wnorowski - VSU
- Maciej Gamrota - CFO
- Jaroslaw Jerzakowski - MGB
- Artur Malek - IND
- Mariusz Matuszewski - IND
- Krzysztof Urbanowicz - IND
- Stanisla Borkowski - SUB
- Werner Engelhardt - SUB
- Andrzej Gladysz - SUB
- Grzegorz Janas - SUB
- Martin Jasinski - SUB
- Anna Sobocka - SUB
- Brandon Von Tobel - SUB